A. MichaelLincoffMDFACC

PubMed

• 5 citations
  Femoral Vascular Closure Devices and Bleeding, Hemostasis, and Ambulation Following Percutaneous Coronary Intervention.
  Guillaume Marquis-Gravel, Laurie-Anne Boivin-Proulx, Zhen Huang, Steven L Zelenkofske, A Michael Lincoff
  Journal of the American Heart Association. 2023-01-03
• 47 citations
  Semaglutide for cardiovascular event reduction in people with overweight or obesity: SELECT study baseline characteristics.
  Ildiko Lingvay, Kirstine Brown-Frandsen, Helen M Colhoun, John Deanfield, Scott S Emerson
  Obesity. 2023-01-01
• 1 citations
  Interaction Between Race and Income on Cardiac Outcomes After Percutaneous Coronary Intervention.
  Anirudh Kumar, Gregory O Ogunnowo, Umesh N Khot, Claire E Raphael, Joanna Ghobrial
  Journal of the American Heart Association. 2022-11-15

Journal Articles

• Impact of bleeding and bivalirudin therapy on mortality risk in women undergoing percutaneous coronary intervention (fron the REPLACE-2, ACUITY, and HORIZONS-AMI trials)  
  Ng VG, Baumbach A, Grinfeld L, Lincoff AM, Mehran R, Stone GW, Lansky AJ, American Journal of Cardiology, 1/1/2016
• Long-term dual antiplatelet therapy for secondary prevention of cardiovascular events in the subgroup of patients with previous myocardial infarction: a collaborative ...  
  Udell JA, Bonaca MP, Collet JP, Lincoff AM, Kereiakes DJ, Costa F, Lee CW, Mauri L, Valgimigli M, Park SJ, Montalescot G, Sabatine MS, Braunwald E, Bhatt DL, European Heart Journal, 1/1/2016
• Utility of glycated hemoglobin for assessment of glucose metabolism in patients with ST-Segment elevation myocardioal infarction  
  Aggarwal B, Shah GK, Randhawa M, Ellis SG, Lincoff AM, Menon V, American Journal of Cardiology, 1/13/2015
• Impact of antiocoagulation regimen prior to revascularization in patients with non-ST-segment elevation acute coronary syndromes: The ACUITY trial  
  Geisler T, Droppa M, Gawaz M, Steinhubl SR, Bertrand ME, Lincoff AM, Cequier AR, Desmet W, Rasmussen LH, Hoekstra JW, Bernstein D, Deliargyris EN, Mehran R, Stone GW, Catheter and Cardiovascular Interventions, 1/2/2015
• Incidence and impact of totally occluded culprit coronary arteries in patients presenting with non-ST-segment elevation myocardial infarction  
  Warren J, Mehran R, Yu J, Xu K, Bertrand ME, Cox DA, Lincoff AM, Manoukian SV, Ohman EM, Pocock SJ, White HD, Stone GW, American Journal of Cardiology, 1/1/2015
• Cardiac troponin I for prediction of clinical outcomes and cardiac function through 3-month follow-up after primary percutaneous coronary intervention for ST-segment e...  
  Hall TS, Hallén J, Krucoff MW, Roe MT, Brennan DM, Agrewall S, Atar D, Lincoff AM, American Heart Journal, 1/1/2015
• Utility of CMR markers of myocardial injury in predicting LV functional recovery: results from PROTECTION AMI CMR sub-study  
  Grover S, Bell G, Lincoff AM, Jeorg L, Madsen PL, Huang S, Low S, Figtree G, Chakrabarty A, Leong DP, Woodman RJ, Selvanayagam JB, Heart, Lung and Circulation Journal, 1/1/2015
• Assessment of the clinical effects of cholesteryl ester transfer protein inhibition with evacetrapid in patients at high-risk for vascular outcomes: Rationale and desi...  
  Nicholls SJ, Lincoff AM, Barter PJ, Brewer HB, Fox KAA, Gibson M, Grainger C, Menon V, Montalescot G, Rader D, Tall AR, McErlean E, Riesmeyer J, Vangerow B, Ruotolo G,..., American Heart Journal, 1/1/2015
• Coronary artery bypass surgery compared with percutaneous coronary intervention for proximal left anterior descending artery treatment in patients with acute coronary ...  
  Mennuni MG, Dangas GD, Mehran R, Ben-Gal Y, Xu K, Généreux P, Brener SJ, Feit F, Lincoff AM, Ohman EM, Hamon M, Stone GW, Journal of Invasive Cardiology, 1/1/2015
• What role for glycoprotein iib/iiia inhibition in contemporary coronary intervention?  
  Lincoff AM, Journal of the American College of Cardiology: Cardiovascular Interventions, 1/1/2015
• Prediction of 1-year mortality and impact of bivalirudin therapy according to level of baseline risk: A patient-level pooled analysis from three randomized trials  
  Yu J, Mehran R, Clayton T, Gibson CM, Brodie BR, Witzenbichler B, Lincoff AM, Deliargyris EN, Gersh BJ, Pocock SJ, Stone GW, Dangas GD, Catheter and Cardiovacular Interventions, 1/1/2015
• Interventional Cardiology: Does an optimal antithrombotic regimen for PCI exist?  
  Lincoff AM, Nature Reviews Cardiology, 1/1/2014
• Varespladib and cardiovascular events in patients with an acute coronary syndrome: the VISTA-16 randomized clinical trial  
  Nicholls SJ, Kastelein JJ, Schwartz GG, Bash D, Rosenson RS, Cavendar MA, Brennan DM, Koenig W, Jukema JW, Nambi V, Wright RS, Menon V, Lincoff AM, Nissen SE; VISTA-16..., Journal of the American Medical Association, 1/1/2014
• Comparison of clinical trial outcome patterns in patients following acute coronary syndromes and in patients with chronic stable atherosclerosis  
  Mahaffey KW, Wojdyla, Pieper KS, Tricoci P, Alexander JH, Lincoff AM, Brennan DM, Bhatt DL, Wallentin L, Harrington RA, Clinical Cardiology, 1/1/2014
• Effect of aleglitazar on cardiovascular outcomes after acute coronary syndrome in patients with type 2 diabetes mellitus; The AleCardio randomized clinical trial  
  Lincoff AM, Tardif JC, Schwartz GG, Nicholls SJ, Ryden L, Neal B, Malmberg K, Wedel H, Buse JB, Henry RR, Weichert A, Cannata R, Svensson A, Volz D, Grobbee DE; for th..., Journal of the American Medical Association, 1/1/2014
• Impact of cigarette smoking on extent of coronary artery disease and prognosis of patients with non-ST segment elevation acute coronary sydromes An analysis from the A...  
  Robertson JO, Ebrahimi R, Lanksy AJ, Mehran R, Stone GW, Lincoff AM, Journal of the American College of Cardiology: Cardiovascular Interventions, 1/1/2014
• Managing acute coronary syndromes: Decades of progress  
  Lincoff AM, Cleveland Clinic Journal of Medicine, 1/1/2014
• Inhibition of delta-protein kinase C by delcasertib as an adjunct to primary percutaneous coronary intervention for acute anterior ST-segment elevation myocardial infa...  
  Lincoff AM, Roe M, Aylward P, Galla J, Rynkiewicz A, Guetta V, Zelizko M, Kleiman N, White H, McErlean E, Erlinge D, Laine M, Dos Santos Ferreira JM, Goodman S, Mehta ..., European Heart Journal, 1/1/2014
• Prognostic implications of creatine kinase-MB measurements in ST-segment elevation myocardial infarction patients treated with primary percutaneous coronary intervention  
  Bagai A, Schulte PJ, Granger CB, Mahaffey KW, Christenson RH, Bell G, Lopes RD, Green CL, Lincoff AM, Armstrong PW, Roe MT, American Heart Journal, 1/1/2014
• Association of glycemic control with mortality in patients with diabetes mellitus undergoing percutaneous coronary intervention  
  Sharma PK, Agarwal S, Ellis SG, Goel SS, Cho L, Tuzcu EM, Lincoff AM, Kapadia SR, Circulation Cardiovascular Interventions, 1/1/2014
• Beta-Blockers and cardiovascular events in patients with and without myocardial infarction: post hoc analysis from the CHARISMA Trial  
  Bangalore S, Bhatt DL, Steg G, Weber MA, Boden WE, Hamm CW, Montalescot G, Hsu A, Fox KAA, Lincoff AM, Circulation Cardiovascular Quality and Outcomes, 1/1/2014
• Effects of the dual peroxisome proliferator-activated receptor-alpha/gamma agonist aleglitazar on renal function in patients with stage 3 chronic kidney disease and ty...  
  Ruilope L, Hanefeld M, Lincoff AM, Viberti G, Meyer-Reigner S, Mudie N, Kirk DW, Malmberg K, Herz M, BMC Nephrology, 1/1/2014
• Effect of anermia on frequency of short- and long-term clinical events in acute coronary syndromes (from the Acute Cahterization and Urgent Intervention Triage Strateg...  
  Kunadian V, Mehran R, Lincoff AM, Feit F, Manoukian SV, Hamon M, Cox DA, Dangas GD, Stone GW, American Journal of Cardiology, 1/1/2014
• Percutaneous coronary revascularization in coronary artery disease: lessons from a single center experience  
  Aksoy O, Tuzcu EM, Ellis SG, Whitlow PL, Cam A, Batizy L, Agarwal S, Franco I, Bajzer C, Simpfendorfer C, Raymond R, Nair R, Cho L, Shishehbor MH, Lincoff AM, Kapadia SR, Catheter and Cardiovasc Intervention, 1/1/2013
• Predictive models for short- and long-term adverse outcomes following discharge in a contemporary population with acute coronary syndromes  
  Kumbhani DJ, Wells BJ, Lincoff AM, Jain A, Arrigain S, Yu C, Goormastic M, Ellis SG, Blackstone E, Kattan MW, Journal of Cardiovascular Disease, 1/1/2013
• Join now to see all

Books/Book Chapters

• Pathophysiology and Pharmacotherapy of Cardiovascular Disease 
  Chapter: Therapy for Acute coronary Syndrome and Unstable Angina. 
  Page 467 - 494Shivapour D, Lincoff AMSpringer-AG, Switzerland2015
• Managing Cardiovascular Complications in Diabetes 
  Chapter: Management of Acute Coronary Syndrome. 
  Page 238 - 266Huff CM, Lincoff AMWiley-Blackwell2014
• Therapeutic Advances in Thrombosis 
  Chapter: Intravenous direct thrombin inhibitors. 
  Page 150 - 165Philip F, Lincoff AMWiley-BlackwellEdition 2nd,2013
• Antiplatelet Agents, Handbook of Experimental Pharmacology 
  Chapter: Antiplatelet Agents in Ischemic Heart Disease. 
  Page 495 - 518May CH, Lincoff AMSpringer-Verlag Berlin, Heidelberg2012
• Cleveland Clinic Cardiology Board Review 
  Chapter: Theodos G, Bavry AA, Lincoff AM 
  Page 575 - 589Theodos G, Bavry AA, Lincoff AMLippincott Williams & Wilkins, Philadephia, PAEdition 2nd,2012
• The Cardiac Care Unit Survival Guide 
  Chapter: Medications used in the management of acute coronary syndrome. 
  Page 62 - 76Jolly M, Lincoff AMLippincott Williams & Wilkins, Philadephia, PA2012
• Antithrombotic Drug Therapy in Cardiovascular Disease 
  Chapter: Direct thrombin inhibitors in acute coronary syndromes. 
  Page 183 - 202Taigen TL, Harvey JE, Lincoff AMEditors: Askari AT and Lincoff AM.Humana Press, New York, NY2009
• Cleveland Clinic Intensive Review of Internal Medicine 
  Chapter: Acute coronary syndromes. 
  Page 836 - 849Jneid H, Rimmerman C, Lincoff AM2009
• The Cleveland Clinic Cardiology Board Review 
  Chapter: Acute myocardial infarction. 
  Page 142 - 153Bavry AA, Lincoff AMEditors: Griffin BP, Rimmerman CM, Topol EJ.Lippincott Williams & Wilkins, Philadelphia, PA2007
• The Cleveland Clinic Cardiology Board Review 
  Chapter: Unstable coronary syndromes. 
  Page 129 - 141Bavry AA, Lincoff AMEditors: Griffin BP, Rimmerman CM, Topol EJ.Lippincott Williams & Wilkins, Philadelphia, PA2007
• Cardiovascular Therapeutics. A Companion to Braunwald's Heart Disease 
  Chapter: Mechanical approaches to percutaneous coronary intervention. 
  Page 121 - 134Karha J, Lincoff AM, Ellis SGEditors: Antman EM.Saunders, Philadelphia, PAEdition 3rd,2007
• Management of the Patients in the Coronary Care Unit 
  Chapter: Acute Coronary Syndromes 
  Lincoff AMEditors: Shishehbor MH, Wang TH, Askari AT, Penn MS, Topol EJ.Lippincott Williams & Wilkins, Philadelphia, PA2007
• Therapeutic Strategies in Thrombosis 
  Chapter: Direct thrombin inhibition during percutaneous coronary intervention. 
  Page 107 - 122Kalahasti V, Lincoff AMEditors: Kristensen SD, De Caterina R, Moliterno DJ.Clinical Publishing, Oxford, UK2006
• Local Drug Delivery For Coronary Artery Disease 
  Chapter: The dexamethasone eluting stent. 
  Page 209 - 213Zhou Z, Wang K, Lincoff AMEditors: Camenzind E, De Scheerder IK.New York: Taylor & Francis, London2005
• The Cleveland Clinic Intensive Review of Internal Medicine 
  Chapter: Acute Coronary Syndromes. 
  Page 838 - 850Jneid H, Rimmerman CM, Lincoff AMEditors: Stoller JK, Michota FA, Mandell BF.Lippincott Williams & Wilkins, Philadelphia, PA2005
• Atherothrombosis and Coronary Artery Disease 
  Chapter: Thrombolytic Therapy. 
  Page 987 - 1016Zidar F, Lincoff AMEditors: Fuster VJ, Topol EJ, Nabel EG.Lippincott Williams & Wilkins, Philadelphia, PAEdition 2nd,2005
• Acute Coronary Syndromes 
  Chapter: Early invasive vs conservative strategies for ACS management. 
  Page 351 - 368L'Allier P, Lincoff AMEditors: Topol EJ.Marcel Dekker, New York, NYEdition 3rd,2005
• Manual of Cardiovascular Medicine 
  Chapter: Ischemic Heart Disease 
  Page 1 - 98Askari A, Lincoff AMEditors: Griffin BP, Topol EJ.Lippincott Williams & Wilkins, Philadelphia, PAEdition 2nd,2004
• Introductory Guide to Cardiac Catheterization 
  Chapter: High-risk coronary angiography. 
  Page 111 - 124Tamberella MR, III, Lincoff AMEditors: Aviles RJ.Lippincott Williams & Wilkins, Philadelphia2004
• Introductory Guide to Cardiac Catheterization 
  Chapter: Post-cath. 
  Page 135 - 140Gurm HS, Lincoff AMEditors: Aviles RJ.Lippincott Williams & Wilkins, Philadelphia2004
• Introductory Guide to Cardiac Catheterization 
  Chapter: Hemostatic devices. 
  Page 125 - 134Ellis BK, Lincoff AMEditors: Aviles RJ.Lippincott Williams & Wilkins, Philadelphia2004
• A Comprehensive Handheld-Based Approach to Cardiovascular Medicine 
  Chapter: PCI Trials: Angioplasty, stenting, IVUS-guidance, and pharmacologic treatment to prevent acute complications and restenosis. 
  Dauterman KW, Lincoff AMEditors: Roffi M, Meier B, Topol EJ.Handheldmed, Inc., Little Rock, AR2004
• New Therapeutic Agents in Thrombosis and Thrombolysis 
  Chapter: Abciximab. 
  Page 349 - 369Bhatt D, Lincoff AMEditors: Sasahara A and Loscalzo J.Marcel Dekker, Inc., New York, NY2003
• Cardiovascular Therapeutics: A Companion to Braunwald's Heart Disease 
  Chapter: Mechanical approaches to percutaneous coronary intervention. 
  Page 865 - 884Lincoff AM, Ellis SGEditors: Antmann EM.W.B. Saunders and Company, Philadelphia, PAEdition 2nd,2002
• Intensive Review of Internal Medicine 
  Chapter: Acute Coronary Syndromes. 
  Page 860 - 873Jneid H, Rimmerman CM, Lincoff AMEditors: Stoller JK, Ahmad M, Longworth DL.Lippincott Williams & Wilkins, Philadelphia, PAEdition 3rd,2002
• Join now to see all

Abstracts/Posters

• Impact of ejection fraction on mortality in patients undergoing PCI. A patient-level pooled analysis from the REPLACE-2, ACUITY, and HORIZONS-AMI Trials.
  Yu J, Dangas G, Baber U, Vlachojannis G, Clayton T, Pocock S, Feit F, Cox D, Brodie B, Lincoff A, Deliargyris E, Gersh B, Gibson CM, Mehran R. Stone G, Journal of the American College of Cardiology, 1/1/2014
• Prediction of Myocardial Infarct Size Using Multiple Concomitant Angiographic, Biochemical and Electrocardiographic Biomarkers in Patients with ST-Segment Elevation My...
  Kuijt WJ, Krucoff MW, Damman P, Lopes RD, Green CL, Pieper KS, Stevens SR, Christenson RH, Tijssen JG, Stone GW, Lincoff AM, de Winter RJ, Roe ME, Circulation, American Heart Association Scientific Sessions, 1/1/2011
• Prediction of Death and Congestive Heart Failure Using Multiple Concomitant Angiographic, Biochemical and Electrocardiographic Biomarkers in Patients with ST-Segment E...
  Kuijt WJ, Roe MT, Green CL, Pieper KS, Stevens SR, Lopes RD, Chistenson RH, Tijssen JG, Stone GW, Lincoff AM, De Winter RJ, Krucoff MW, Duke Clinical Research Institut..., Journal of American College of Cardiology, American College of Cardiology Annual Scientific Session, 1/1/2011
• Relationship Between Bleeding and Mortality in Patients with Dual Antiplatelet Therapy vs Aspirin Alone: Results From the CHARISMA trial.
  Berger JS, Bhatt DL, Steg GP, Steinhubl SR, Montalescot G, Shao M, Hacke W, Fox KA, Berger PB, Topol EJ, Lincoff AM, NYU School of Medicine, New York, NY, Journal of American College of Cardiology, American College of Cardiology Annual Scientific Session, 1/1/2011
• Prognosis of Patients Presenting with Acute Coronary Syndromes with Elevated Serum Troponins and Non-obstructive Coronary Artery Disease: The ACUITY Trial.
  Planer D, Lincoff AM, Moses JW, White HD, Dangas G, Fahy M, Mehran R, Stone GW, Journal of American College of Cardiology, TCT, 1/1/2011
• Outcomes of patients with acute coronary syndromes and prior coronary artery bypass grafting: Analysis from the Acuity trial.
  Nikolsky E, Mehran R, Ohman EM, Bertrand ME, Lincoff AM, Moses JW, Cristea E, White HD, Fahy M, Lansky AJ, Stone GW, Journal of the American College of Cardiology, 1/1/2010
• Impact of anticoagulation regimen in patients with non-ST-elevation acute coronary syndromes undergoing an early invasive sgtrategy independent of revascularization. T...
  Geisler T, Gawasz M, Steinhubl SR, Bertrand ME, Lincoff AM, Cequier AR, Desmet W, Rasmussen LH, Hoekstra J, Mehran R, Stone GW, Journal of the American College of Cardiology, 1/1/2010
• Transfusing old stored blood after an early invasive strategy for ACS is associated with increased long term mortality.
  Carrigan TP, Azimpour F, Shao M, Figueroa P, Lincoff M, Journal of the American College of Cardiology, 1/1/2010
• Impact of left ventricular function on mortality in patients with acute coronary syndromes: Analysis of the acute catheterization and urgent intervention triage strate...
  Lansky AJ, Ng V, Goto K, Fahy M, Mehran R, Ebrahimian R, Hamond M, Ohman EM, Feit F, Manoukian S, Lincoff M, Stone GW, Journal of the American College of Cardiology, 1/1/2010
• Pre-treatment with thienopyridines reduces the amount of myonecrosis in acute coronary syndrome patients invasively managed: Insights from the CHAMPION trials.
  Leonardi S, Stebbins A, Lopes RD, Lokhnygina Y, Bhatt DL, Stone GW, Lincoff M, Dauerman HL, Gibson M, White HD, Parick K, Gruberg L, Herrmann HC, McLaurin BR, Goodman ..., Circulation, 1/1/2010
• Outcomes of unprotected left main coronary artery percutaneous intervention as compared to multivessel interventions.
  Agarway S, Zaman T, Tuzcu EM, Shishehbor M, Lincoff AM, Whitlow P, Bajzer C, Franco I, Nair R, Raymond R, Ellis SG, Kapadia SR, Circulation, 1/1/2010
• Glycemic and lipid effects and cardiovascular safety of a novel dual peroxisome proliferator activated receptor agonist.
  Lincoff AM, Henry RR, Mudaliar S, Chognot C, Rabbia M, Herz M, Journal of the American College of Cardiology, American College of Cardiology Annual Scientific Session, 1/1/2009
• Impact of different antithrombotic regimens on ischemic and hemorrhagic outcomes following percutaneous coronary intervention in elderly: Pooled analysis fromteh REPLA...
  Nikolsky E, Mehran R, Parise H, Lansky AJ, Dangas GD, Manoukian SV, Voeltz M, Alexander KP, Ohman EM, Dudek D, Lincoff AM, Stone GW, Journal of the American College of Cardiology, 1/1/2009
• Outcomes of patients with diabetes mellitus undergoing PCI treated with bivalirudin versus heparin plus a glycoprotein IIb/IIIa inhibitor: Pooled analysis from the REP...
  Feit F,Gurm HS, Witzenbichler B, Parise H, Lincoff AM, Manoukian SV, White HD, Pocock, SJ, Mehran R, Stone GW, Journal of the American College of Cardiology, 1/1/2009
• Bivalirudin therapy reduces 30 day bleeding complications in patient with chronic renal insufficiency: A pooled analysis of the REPLACE-2, ACUITY, and HORIZONS Trials.
  Mehran R, Dangas GD, Lansky AJ, Nikolsky E, Chew DP, Lincoff AM, Topol E, Pocock SJ, Witzenbichler B, Parise H, Stone GW, Journal of the American College of Cardiology, 1/1/2009
• Impact of gastrointestinal bleeding on outcomes of patients treated with contemporary antithrombotic strategies: Pooled analysis from 3 randomized trials.
  Nikolsky E, Mehran R, Lansky A, Caixeta A, Dangas GD, Weisz G, Giuran IB, Fahy M, Lincoff AM, Witzenbichler B, Stone GW, Journal of the American College of Cardiology, 1/1/2009
• Bivalirudin therapy reduces 30 day bleeding complications in women undergoing PCI for acute coronary syndrome: Results of the REPLACE-2, ACUITY and HORIZONS pooled ana...
  Lansky AJ, Parise H, Grinfeld L, Lincoff AM, Pocock SJ, Mehran R, Stone GW, Journal of the American College of Cardiology, 1/1/2009
• Clinical and angiographic risk score to predict ischemic outcomes as 1 year I acute coronary syndromes: The ACUITY risk score.
  Lansky AJ, Goto K, Fahy M, Jung JA, Nikolsky E, Ohman ME, White HD, Bertrand ME, Lincoff AM, Moses J, Mehran R, Stone GW, Journal of the American College of Cardiology, 1/1/2009
• Bivalirudin versus heparin plus glycoprotein inhibitors in patients with acute coronary syndromes and prior coronary artery bypass grafting: Analysis from the Acuity T...
  Nikolsky E, Mehran R, Ohman ME, Bertrand ME, Lincoff AM, Moses JW, Cristea E, White HD, Goto K, Fahy M, Lansky AJ, Stone GW, The American Journal of Cardiology, 1/1/2009
• Drug-eluting versus bare-metal stents for bare-metal in-stent restenosis.
  Singh IM, Filby SJ, El Sakr F, Gorodeski EZ, Lincoff AM, Ellis SG, Shishebor MH, The American Journal of Cardiology, 1/1/2009
• One-year mortality in patients with diabetes mellitus undergoing pci: Pooled analysis from the REPLACE-2, ACUITY, and HORIZONS-AMI trials.
  Feit F, Gurm HS, Manoukian SV, Lincoff AM, Witzenbichler B, Parise H, White HD, Mehran R, Stone GW, The American Journal of Cardiology, 1/1/2009
• Long-term mortality with bivalirudin therapy in women undergoing pci for acute coronary syndrome: Results of the REPLACE-2, ACUITY and HORIZONS pooled analysis.
  Lansky AJ, Parise H, Grinfeld L, Lincoff AM, Mehran R, Stone GW, The American Journal of Cardiology, 1/1/2009
• Long-term mortality after pci in patients with chronic kidney disease: A pooled analysis of the REPLACE-2, ACUITY and HORIZONS Trials.
  Mehran R, Nikolsky E, Dangas GD, Chew DP, Lincoff AM, Caixeta A, Topol E, Witzenbichler B, Parise H, Lansky AJ, Stone GW, The American Journal of Cardiology, 1/1/2009
• Clinical outcomes of drug-eluting versus bare-metal in-stent restenosis.
  Singh IM, Filby SJ, El Sakr F, Gorodeski EZ, Lincoff AM, Ellis SG, Shishebor MH, The American Journal of Cardiology, 1/1/2009
• Aleglitazar, a balanced peroxisome proliferator-activated receptor (PPAR) a/y agonist, provides beneficial effects on cardiovascular markers of inflammation and clotting.
  Henry RR, Lincoff AM, Mudaliar S, Chognot C, Rabbia M, Herz M, Circulation, 1/1/2009
• Join now to see all

Lectures

• "Effect of Aleglitazar on Cardiovascular Outcomes After Acute Coronary Syndrome in Patients With Type 2 Diabetes Mellitus. The AleCardio Randomized Clinical Trial." 
  Washington, DC - 1/30/2014
• "Evaluation of the Dual PPAR-alpha/gamma Agonist Aleglitazar to Reduce Cardiovascular Events in Patients with Acute Coronary Syndrome and Type 2 Diabetes Mellitus: the... 
  Washington, DC - 1/29/2014
• "Managing the Epidemic: What's New in Treating Patients with Diabetes and Can We Expect Better Cardiovascular Outcomes?: A Frank Debate About Current Challenges and Op... 
  Washington, DC - 1/29/2014
• "Unstable Angina and Non-ST Elevation MI." 
  Cleveland Clinic, Cleveland, OH - 1/25/2014
• "Insights from Recent Antiplatelet and Antithrombotic Trials." 
  Lexington, KY - 1/19/2014
• "Lessons Learned from the ALECARDIO Trial for Aleglitazar." 
  Chicago, IL - 1/18/2014
• "Acute Management of Patients with Diabetes and ACS: Do They Benefit from More Aggressive Management?" 
  Chicago, IL - 1/17/2014
• "Strong Evidence Warrants Universal Adoption of Clopidogrel Pretreatment." 
  San Diego, CA - 1/16/2014
• "The REG1 Anticoagulation System: Factor IX Inhibition Using RNA Aptamer Technology." 
  Washington, DC - 1/15/2014
• "Screening For Asymptomatic Obstructive Coronary Artery Disease Among High-Risk Diabetic Patients Using Coronary CT Angiography: Primary Results of FACTOR-64, a Random... 
  Chicago, IL - 1/15/2014
• "The REGULATE-PCI Trial - REG-1 versus Bivalirudin for Coronary Intervention." 
  San Diego, CA - 1/15/2014
• "Bivalirudin Should be Default Strategy in PCI of ACS." 
  San Diego, CA - 1/14/2014
• "Should We Target Triglycerides and HDL in Patients with Chronic Ischemic Heart Disease?" 
  San Diego, CA - 1/13/2014
• "Acute Coronary Syndromes - 2014." 
  Fairview Hospital, Cleveland, OH - 1/7/2014
• "Plenary - Something That's Been Bugging Me Lately." 
  Monterey, CA - 1/6/2014
• "Spreading the Health - Innovations across public health and the healthcare industry." 
  Monterey, CA - 1/5/2014
• "The Heart of the (Heart) Matter - Fostering Healthier Hearts and Reversing Heart Disease. Insights & Innovations." 
  Monterey, CA - 1/4/2014
• "Towards the Cures - The Promise of Current Autism, Alzheimer's, AIDS, Cancer, and Heart Disease Research." 
  Monterey, CA - 1/4/2014
• "Mechanisms and Genetics: The Science Behind CETP and PCSK9 Inhibitors." 
  Barcelona, Spain - 1/1/2014
• "Management of NSTEMI." 
  Cleveland, OH - 1/31/2013
• "Anticoagulant Agents." 
  Cleveland, OH - 1/31/2013
• "Cardiovascular Risk Reduction in Patients with Type 2 Diabetes: Unique Challenges for the Cardiovascular Specialist." 
  Amsterdam, The Netherlands - 1/31/2013
• "Coagulation Cascade and Targets." 
  Cleveland, OH - 1/29/2013
• "The Evolving Role of Dual PPAR Agonists for Cardiovascular and Stroke Risk Reduction in the Diabetic Patient with ACS." 
  Munich, Germany - 1/25/2013
• "The Changing Face of Dual Anti-Platelet Therapy: Implications for the Internist." 
  Cleveland Clinic - 1/25/2013
• Join now to see all

Other

• "Secondary Prevention of ACS and CAD - American College of Chest Physicians Antithrombotic Guidelines." 
  A. M. Lincoff, MD, Venous Disease Coalition Webcast
  www.theheart.org
  Chicago, IL - 1/25/2012
• "A New Standard of Anticoagulation Therapy in PCI." 
  A. M. Lincoff, MD, CME accredited satellite and web broadcast
  Cleveland, OH - 1/9/2003
• "Complementary Therapies in the Cath Lab: Drugs and Devices." 
  A. M. Lincoff, MD, Day in Review, Chicago '03, theheart.org (CME accredited web broadcast)
  Chicago, IL - 1/1/2003
• "REPLACE-2 Trial." 
  A. M. Lincoff, MD, American College of Cardiology Audio Journal (ACCEL) Interview, American Heart Association Scientifi
  Chicago, IL - 1/1/2002
• "Thrombocytopenia after percutaneous coronary intervention." 
  Lincoff AM, ACC Spotlight Series:ACCIS 2001, Boston: Physician Education
  1/1/2001
• "Enzyme Leaks and Gushes." 
  A. M. Lincoff, MD, Coronary Stenting: Pitfalls Along the Road, Canadian Association of Interventional Cardiology, Inter
  1/2/1999
• "Empiric Use of GP IIb/IIIa Antagonists in Acute Coronary Syndromes." 
  A. M. Lincoff, MD, The Next Revolution in Clinical Cardiology: Advances in Antiplatelet Therapy - Interactive CME Satel
  1/30/1998
• "Long Term Results of the EPISTENT Trial." 
  A. M. Lincoff, MD, American College of Cardiology Extended Learning Series (ACCEL)
  1/10/1998
• "Abciximab and Eptifibatide in the Management of Acute Myocardial Infarction." 
  A. M. Lincoff, MD, American College of Cardiology Extended Learning Series (ACCEL)
  1/10/1998
• Catheter-based drug delivery for restenosis. 
  Eccleston DS, Lincoff AM, Advanced Drug Delivery Reviews
  1/1/1997
• "Striking Clinical Benefit with Platelet GP IIb/IIIa Inhibition by c7E3 Among Patients with Unstable Angina: Outcome in the EPIC Trial." 
  A. M. Lincoff, MD, American College of Cardiology Extended Learning Series (ACCEL)
  1/15/1994
• "Local Drug Delivery in the Coronary Arteries." 
  A. M. Lincoff, MD, American College of Cardiology Extended Learning Series (ACCEL)
  1/13/1994
• An update on coronary thrombolysis. 
  Brener SJ, Lincoff AM, Topol EJ, Hospital Medicine
  1/1/1993
• "Indications and Contraindications for Thrombolytic Therapy." 
  A. M. Lincoff, MD, Medical News Network
  1/1/1993
• Heparin, aspirin, and new agents for prevention of thrombotic complications in coronary interventions. 
  Evans DJ, Lincoff AM, Topol EJ, Cardio Intervention
  1/1/1992
• Pre-procedural assessment of risk for ischemic complications during coronary angioplasty. 
  Lincoff AM, Ellis SG, Choices in Cardiology
  1/1/1992
• Influence of random noise on parameter estimates derived from a mathematical model of the arterial uptake of lipoprotein molecules. 
  Sevick EM, Borovetz HS, Lincoff AM, American Society of Mechanical Engineers (ASME) Biomechanics Symposium
  1/1/1985
• Separation system for recovery of ethylene and light products from a naphtha-pyrolysis gas stream: preliminary design and economic analysis. 
  Lincoff AM, Grossman IE, Blau GE, CACHE Process Design Case Studies, Vol 1
  1/1/1983
• Regional pulmonary perfusion from dynamic computerized tomography. 
  Lincoff AM, Borovetz HS, Hardesty RL, American Institute of Chemical Engineers (AIChE) Symposium Series "Fundamentals in the Life Sciences
  1/1/1983
• The EPISTENT Diabetic Substudy. 
  Marso SP, Lincoff AM, Harrison's Online, Braunwald E, ed
  http://harrisons.accessmedicine.com/server_java/Arknoid/amed/harrisons/ex_editorials/edl2340_p01.html
  New York, NY
• Direct antithrombin therapy in acute myocardial infarction. 
  Lincoff AM, UpToDateTM BRD Inc. (Rose BD ed)
  Wellesley, MA
• Heparin therapy in acute myocardial infarction. 
  Lincoff AM, UpToDateTM BRD Inc. (Rose BD ed)
  Wellesley, MA
• Antiplatelet agents in acute myocardial infarction. 
  Lincoff AM, UpToDateTM BRD Inc. (Rose BD ed)
  Wellesley, MA
• Join now to see all